A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 Vaccine
Clinical trial NCT05442684 · WITHDRAWN
Trial details
- NCT number
- NCT05442684
- Sponsor
- CanSino Biologics Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2023-03-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.